$1.36
-0.02-1.45%
Purple Biotech Ltd
PPBTNASDAQ
Purple Biotech (PPBT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '21 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | $-0.98 | $-1.06 | $-3.40 | $-2.60 | — |
| Actual | $-0.41 | $-0.09 | $-19.85 | $-2.90 | $-202.00 |
| Surprise | +58.2% | +91.5% | -483.8% | -11.5% | — |
| Revenue | |||||
| Estimate | — | — | — | — | — |
| Actual | $0 | — | $0 | — | $0 |
| Surprise | — | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-2.88 | $-3.00 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.41 | $-0.98 | 58.2 % |
| Q1 | May 15, 2026 | $-0.09 | $-1.06 | 91.5 % |
| Q4 | Mar 13, 2026 | $-19.85 | $-3.40 | -483.8 % |
| Q3 | Nov 14, 2025 | $-2.90 | $-2.60 | -11.5 % |
